Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

INNZ MEDICAL ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   3.3% 8.3% 11.0% 6.5% 4.5% 6.0% 16.7% 16.4%   Credit score (0-100)   56 31 22 35 46 37 10 11   Credit rating   BBB BB BB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,606 2,218 2,494 3,434 3,650 3,132 0.0 0.0   EBITDA   162 120 28.3 827 829 184 0.0 0.0   EBIT   158 119 28.3 827 829 184 0.0 0.0   Pre-tax profit (PTP)   131.5 103.7 -20.3 798.0 755.9 -51.1 0.0 0.0   Net earnings   91.5 77.6 -22.9 616.3 572.3 -93.0 0.0 0.0   Pre-tax profit without non-rec. items   131 104 -20.3 798 756 -51.1 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1.0 0.0 0.0 0.0 0.0 39.3 0.0 0.0   Shareholders equity total   194 271 249 865 837 244 164 164   Interest-bearing liabilities   822 622 313 893 14.9 2,827 0.0 0.0   Balance sheet total (assets)   1,574 3,046 3,553 5,979 3,990 5,768 164 164   Net Debt   586 112 158 352 -356 2,407 -164 -164     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,606 2,218 2,494 3,434 3,650 3,132 0.0 0.0   Gross profit growth   3.8% 38.2% 12.4% 37.7% 6.3% -14.2% -100.0% 0.0%   Employees   2 4 4 4 4 4 0 0   Employee growth %   0.0% 100.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,574 3,046 3,553 5,979 3,990 5,768 164 164   Balance sheet change%   167.5% 93.4% 16.7% 68.2% -33.3% 44.6% -97.2% 0.0%   Added value   162.2 119.6 28.3 826.5 828.9 184.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -8 -2 0 0 0 39 -39 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   9.9% 5.3% 1.1% 24.1% 22.7% 5.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   16.5% 5.1% 0.9% 17.3% 16.6% 3.8% 0.0% 0.0%   ROI %   31.8% 12.1% 3.4% 62.8% 56.6% 8.6% 0.0% 0.0%   ROE %   61.8% 33.4% -8.8% 110.7% 67.3% -17.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   12.3% 8.9% 7.0% 14.5% 21.0% 4.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   361.5% 93.9% 558.3% 42.6% -42.9% 1,305.3% 0.0% 0.0%   Gearing %   424.0% 229.1% 126.1% 103.2% 1.8% 1,158.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   11.3% 2.1% 10.4% 4.7% 16.1% 16.5% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.5 0.7 0.5 0.8 0.6 0.4 0.0 0.0   Current Ratio   1.1 1.1 1.1 1.2 1.3 1.1 0.0 0.0   Cash and cash equivalent   235.7 509.7 155.2 540.7 370.5 419.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   192.9 329.2 404.5 1,024.0 995.6 374.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   81 30 7 207 207 46 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   81 30 7 207 207 46 0 0   EBIT / employee   79 30 7 207 207 46 0 0   Net earnings / employee   46 19 -6 154 143 -23 0 0